Medical Companies in France

InFlectis BioScience is a private clinical stage company aiming at targeting and modulating interactions between proteins involved in key human pathophysiological processes. The company is developing small molecule drugs that specifically target the Integrated Stress Response (ISR). Exploiting the ISR’s natural defense offers tremendous potential for the development of a new class of therapies. Led by InFlectis, this area of research is rapidly advancing, resulting in new treatments under development for a variety of disease affecting the central nervous system (CNS), peripheral nervous system (PNS) and inflammation.

StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs.

Atlantic Instrument For Research (AI4R) is the world leader in digital real-time autoradiography, a new-generation imaging solutions for preclinical studies. Our company has designed a new autoradiograph: the BeaQuant. Our device uses an innovative technology (gaz detection) to give researchers a quantitative mapping of radioactivity in a sample (alpha and beta radioisotopes) . Users will experience the highest resolution in the market for autoradiographic analysis, shorter acquisition time, complete safety and unique versatility (with features such as: QWBA or dual-isotope analysis). The BeaQuant is the perfect tool to establish in vitro–in vivo correlation. If you are interested in learning more about our technology, please feel free to visit our website and contact us!

New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine.

ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics to treat severe forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS® platform, which uses a novel technology to encapsulate drug substances inside red blood cells, ERYTECH is developing a pipeline of product candidates for patients with high unmet medical needs. ERYTECH’s primary focus is on the development of product candidates that target the altered metabolism of cancer cells by depriving them of amino acids necessary for their growth and survival. The Company’s lead product candidate, eryaspase, which consists of L-asparaginase encapsulated inside donor-derived red blood cells, targets the cancer cell’s altered asparagine and glutamine metabolism. Eryaspase is in Phase 3 clinical development for the treatment of second-line pancreatic cancer and in Phase 2 for the treatment of triple-negative breast cancer. ERYTECH is based in Lyon, France and Cambridge, MA, USA, and has manufacturing sites in Lyon, France, and Princeton, New Jersey, USA.. ERYTECH is listed on the Nasdaq Global Select Market in the United States (ticker: ERYP) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: ERYP).

We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.

Fab’entech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease. After having developed Fabenflu®, a product indicated for the treatment of avian influenza (H5N1) in human, Fab’entech is currently focusing on 3 products: a biodefense antidote developed in collaboration with the French army, a treatment for drug intoxication developed in a confidential indication, and an Ebola therapy developed with the support of the European Commission after having been identified by the WHO as the unique therapeutic solution in Europe in 2014.

Flash Therapeutics is a World-class CDMO expert in lentiviral vector manufacturing : With our continuum from research to the clinic we support you throughout your projects from R&D to GMP grade. We provide purified and highly concentrated particles from small scale to large scale with the same vector specifications. Flash Therapeutics provides both integrative lentiviral vectors and non-integrative LentiFlash® particles. Lentiviral vectors : Conventional lentiviral vectors, which lead to DNA integrated into the genome, are a leading delivery method for applications which require a stable and long-term gene expression. Ideal for Gene Therapy and Immunotherapy. LentiFlash® particles : LentiFlash® combines a transient expression with a safe and efficient RNA delivery. This proprietary technology allows the delivery of multiple RNA species, without any genomic scar. Ideal for Regenerative Medicine, Gene Editing and Vaccination / Immunotherapy studies Contact us to design your project !

Livmed's is a software platform that provides home medicine delivery services for fellow citizens and healthcare players.

Nova provides its jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers and not-for-profit organizations. Jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the R&D of new therapies for the benefit of patients: identify best responders, optimise the drug's regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials. Predict trial outcomes before advancing to real-world clinical trials and ultimately design studies that are more likely to succeed with Jinkō®.

Patients are more important than everything. On a daily basis, we focus on and improve the way surgeons care patients. We put all of our expertise to enhanced patient follow-up and simplify surgeons life. Medical images were the last revolution in patient care. We believe they are still under exploited. We believe that new powerfull technologies can help and we want to bring it to surgeons. Easily and intuitivly. These technologies are relevant only if it is simple and give the right information at the right moment. Every day, we work hard to design with surgeons the tools that revolutionize patient follow-up and suit the surgeon needs just like they need it. Nurea's mission is to help surgeons and patients. As a start-up, we are devoted to our users. They are the experts and only them know what is the best way to deliver our technology. Our products have to be simple and intuitive to be easily included in our users workflow. That is why they are at the center of our developments. We believe that helping is first listening and understanding. We spend time in hospitals, with surgeons to understand their work, their challenges and their constraints. Our goal is to design what can make their life and patients life more confortable.

OSE Immunotherapeutics is an integrated biotech company focused on developing first-in-class assets targeting cancer and inflammatory diseases. A current well-balanced first-in-class clinical pipeline including: • Tedopi® (T-cell specific immunotherapy): Company’s most advanced product; positive results for Ph 3 in NSCLC in secondary resistance after CKI failure. Other sponsored combo Ph 2 trials in solid tumors ongoing. • OSE-279 (anti-PD1) advanced preclinical stage • OSE-127 (humanized mAb antagonist of IL-7R); ongoing Ph 2 in Ulcerative Colitis; ongoing preclinical research in leukemia • VEL-101/FR104 (anti-CD28 mAb) developed in partnership with Veloxis in transplantation; ongoing Ph 1/2 in renal transplant (sponsor Nantes University Hospital); Ph 1 ongoing in the US (sponsor Veloxis). • BI 765063 (anti-SIRPα mAb on CD47/SIRPα pathway) developed in partnership with Boehringer Ingelheim in advanced solid tumors; positive Ph 1 dose escalation results in mono and in combo, in particular with anti-PD-1 antibody ezabenlimab; BI sponsored international Ph 1b clinical trial ongoing in combo with ezabenlimab alone or with other drugs in recurrent/metastatic HNSCC and HCC. OSE Immunotherapeutics expects to generate further significant value from its two proprietary drug discovery platforms, which are central to its ambitious goal to deliver next-generation first-in-class immunotherapeutics: • BiCKI® platform focused on immuno-oncology (IO) is a bispecific fusion protein platform built on the key backbone component of anti-PD1 combined with a new immunotherapy target to increase anti-tumor efficacy. Most advanced BiCKI® candidate is targeting anti-PD1xIL-7. • Myeloid platform focused on optimizing the therapeutic potential of myeloid cells in IO & immuno-inflammation (I&I). OSE-230 (ChemR23 agonist mAb), most advanced candidate generated by the platform, with the potential to resolve chronic inflammation.

Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures. Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, VX1, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With VX1, operators keep their go-to navigation system and catheters. The VX1 real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation. VX1 is CE marked and FDA cleared. VX1 was the first artificial intelligence-based software solution to be FDA cleared in the interventional cardiology space. Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.

Intrasense develops and markets Myrian®, a software solution allowing medical images visualization and analysis for improved productivity and enhanced patient care. This new vendor neutral viewer features a multimodal platform and a full set of clinical modules, fully integrable in any healthcare system. Today, we equip more than 800 sites worldwide. Learn more about who we are.

TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.

We're hiring ! https://wandercraft.welcomekit.co/ Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia walked human-like, autonomously and without crutches. The Wanderteam walks on the edge of robotics. We cooperate with world class university labs and medical centers in Europe and the US. Atalante is not only an exoskeleton. Atalante allows patients to stand up, without crutches. Atalante allows patients to finally be able to watch their loved ones in the eyes. Atalante allowed them to walk over 2 million steps. But above all, Atalante made them smile again. Atalante made 546 patients smile again. 546 patients who have chosen to place their trust in us. Join us to contribute to changing the lives of millions of persons. You will work in a supportive, fun and agile environment. You will have stunning colleagues, composing one of the best walk robotics teams in the world and chosen because they are selfless team players and not lone geniuses. Expect to be challenged: we do things that no one has done yet. Expect to have to work fast: we test and learn. Expect to have to aim at perfection: we make advanced technology exos that help mobility impaired persons and impact their health and happiness – not pizza delivery apps. Expect to get a ‘Wow’ each time you explain your job to your friends.

We design, manufacture and market innovative solutions for shredding and sterilization of infectious waste for hospitals, medical centers, laboratories or any other healthcare waste facilities

💡 French designer of medical devices in the fields of asthma and allergy 📍 Normandy, France 🎓 Company certified ISO 13485:2016, medical device standard The Laboratory OptimHal-ProtecSom is a Norman research SME (Small and Medium-sized Businesses) which designs and manufactures in France medical devices for the lung deposition of medicine, asthma and allergy. The company, which dedicates a third of its resources directly to research, expands in part through an assertive politic of partnership: - Partnerships for the distribution of its devices, currently available in 30 countries through a network of 15 exclusive partners. - Partnerships in research with several university teams from France, Canada and the United States. - Industrial partnerships, including Bosch’s Norman factory for the industrialization of our last electronic device. Joint project from our multidisciplinary research team and those partners lead to several innovations and numerous patents, some co-owned with public research bodies such as INSERM or university laboratories in particular the University of Normandy or the François Rabelais University of Tours. All devices presently marketed by the Laboratory OptimHal-ProtecSom benefited from these research efforts, were developed in France with ISO 13485:2016-certified processes and are manufactured under the same quality management system certifications.

Reconnus pour notre expertise et notre savoir-faire, nous sommes une marque française singulière dans l’univers de la contactologie depuis 40 ans. En concevant et fabriquant des gammes de lentilles de contact sur mesure dans nos locaux en région parisienne, nous proposons à nos clients en France et à l’international, une expérience unique basée sur une connaissance approfondie des troubles de la vision et sur une prise en charge personnalisée des besoins de chacun. Au-delà de notre technologie de pointe visant à repousser les limites des performances visuelles, nous sommes une entreprise à taille humaine plaçant chaque individu, quel qu’il soit, au cœur de nos préoccupations, tant dans notre approche produit que notre approche client. Cette démarche se reflète également dans les valeurs partagées par l’ensemble nos collaborateurs et dans les relations qui nous lient, depuis 40 ans, à notre écosystème.

Manufacturer and Distributor of Protective Medical Equipment, Made in France. Surgical Face Masks, TYPE IIR, FFP2, FFP3.

Janton est l’un des principaux fabricants et fournisseurs de matériel dans le milieu du grand appareillage orthopédique. Janton est capable de répondre aux besoins et demandes spécifiques des professionnels du positionnement.

At DESKi, we focus on creating a smarter path to heart exams for all, actively taking on the world’s #1 killer, Heart Disease. By leveraging the skills of our audacious and committed team, we created HeartFocus in 2023, a ground-breaking AI-powered software, designed to let any healthcare professional perform heart exams with precision, anywhere. Based in Bordeaux, France, our team is international, committed and believe No heart can wait ™

Exoneo specializes in biomechanical engineering for the orthopaedic industry, providing innovative, cutting-edge solutions. At Exoneo, we are dedicated to creating durable and accessible prosthetics and orthotics capable of reproducing the natural movement of the limbs. We are driven by the desire to design products that are universal. Our creativity and expertise are the key assets that enable us to innovate and design unique products found nowhere else in the orthopaedic field. At Exoneo, we all share the same goal: to put people at the heart of all our thinking and innovations. We firmly believe that our commitment to putting people at the center of everything we do is what enables us to create superior products that meet the real needs of our customers. To do this, we ensure that our products are ultra-comfortable, durable and accessible in order to help in regaining freedom of movement, whether you live in France or elsewhere in the world. Our products are not only beneficial for the individual, but also make a positive contribution to the economy, society and the environment. Our expertise in biomechanics, our boldness and our ethics make Exoneo the orthotics and prosthetics company par excellence. If you'd like to find out more about what we do, please don't hesitate to contact us. Visit our website : https://exoneo.eu/

VitaDX develops software solutions to detect cancer using image processing and artificial intelligence. For more information check out our website: www.vitadx.com Follow us on twitter @VitaDX_SA

PROTEOR is the leader of P&O fitting in France and its expertise is recognized all over the world. PROTEOR develops two activities : - Custom-made orthopedic fitting of Patients thanks to a network of fitting centers set up near hospitals, clinics and rehabilitation centers to ensure geographic proximity with the patients. - Design, manufacture and sales of components for prosthesis, limb orthosis and spinal orthosis for the Professionals of the orthopedic field.

NEW BRAND l NEW NAME l SAME MISSIONS 🚀 Because innovating together means innovating better. Rodin4D, TechMed 3D and Vorum join forces to become Qwadra. 💪 With over 70 years of combined expertise, 1000 customers in more than 85 countries, quick replies across time zones, 5 languages spoken, and partners worldwide, Qwadra stands as the global leader in CAD/CAM solutions for orthopedics today and tomorrow.​ Each company has its objectives, its own needs, and its particular constraints. To satisfy them all, we offer different solutions that can be adapted to your company, your equipment, and your way of working.

One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission of Pixium Vision. Two novel life changing Bionic Vision Systems developed, with active implantable prostheses, that are intended to compensate for vision loss and blindness from retinal degeneration, like Dry Age-Related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP), enabling to regain partial central visual perception and lead more independent lives. Advances in neuro-ophthalmology, innovative state of the art biomedical / bioelectronic technologies, smart bio-inspired bio-mimetic algorithms and AI, and miniaturization of micro/nano-electronics, enable minimal invasive retinal surgery, and develop systems that could provide blind people with a form of prosthetic bionic vision. • PRIMA (Subretinal) a miniaturized wireless photovoltaic implant platform initially for Dry-AMD. The company is conducting first-in-human feasibility trials in Europe and the US. • IRIS®II (Epiretinal) its first System for RP, equipped with a bio-inspired camera, an implant with 150 electrodes, designed to be explantable. Formed in Dec 2011, a bioelectronics technology company specialized in neuromodulation to restore a form of prosthetic vision to compensate for blindness. Listed on Euronext Paris stock exchange in June 2014. Collaborates with a global ecosystem of scientific and clinical partners spanning the prestigious Vision research institutions including: Institut de la Vision Paris, Stanford University California, Moorfields Eye Hospital London, and Institute of Ocular Microsurgery (IMO) Barcelona. twitter: @PixiumVision

DentalMonitoring, powered by AI, is the orthodontic industry’s only FDA-approved and EU-MDR-Certified remote monitoring solution. The platform is revolutionizing the orthodontic experience for patients, parents, and practitioners. Clinicians use DentalMonitoring to see every patient weekly and schedule appointments based on how their patient’s biology responds to treatment. ScanAssist guides patients through the scanning experience and ensures high-quality images with meaningful clinical information. DentalMonitoring makes treatment more convenient for patients who are better educated and compliant because of in-app messaging, automated notifications, and annotated videos and photos. AI-powered analysis of patient scans, automated notifications, and team instructions allows teams to increase their efficiency and clinical effectiveness. The solution works for any patient, in any treatment phase or appliance. DM Insights lets practitioners explore patterns and trends in practice data to make clinical improvements and increase efficiencies. Learn more: www.dental-monitoring.com

Acteur important du marché Européen de l'équipement médical, le groupe Winncare s'implique avec détermination à améliorer le quotidien des personnes en perte d'autonomie au domicile et en collectivités en leur offrant des solutions adaptées à leurs besoins. Nos équipes partagent la même philosophie: proposer des produits et services de qualité irréprochable.

PhysioAssist est une société de matériel médical qui a développé une expertise en rhéologie, étude de la physique du mucus bronchique. Après plusieurs années de recherches, un signal vibratoire pneumatique efficace a été caractérisé pour agir sur le mucus intra pulmonaire, le liquéfier et le drainer. Ce signal est délivré par le dispositif médical Simeox, qui stimule le mucus bronchique par dépressions successives, tout en assurant une expiration passive. Simeox est destiné aux patients atteints de pathologies respiratoires chroniques.

Infimed is a player specializing in the financial rental of medical equipment for healthcare professionals.

Ambler is an intermediation platform that connects health care prescribers to ambulance companies.

Electroducer: a device to secure and optimize TransHeart Valve (THV) & Percutaneous Coronary Interventions (PCI), a rapid Pacing using Left Ventricular Guidewire. Mechanical Device for simplified cardiac procedures: - Patents pending - Class II device Provides Temporary Pacing without Pace Maker: - During THV (TAVI, TMVR, TTVR) - During complex PCI (Rotablator, STEMI) Plug on usual interventions devices: - Usual introducers

Laclarée develops a pair of adaptive eyeglasses for presbyopia. Its patented technology allows the eyeglasses to adapt in real-time to the scene viewed by the wearer. This major innovation will help milllions of people 45+ years, who are not satisfied with current solutions (progressive lenses, multiple pairs, etc...).

CardioRenal uses the advanced technologies to develop digital therapeutic solutions.

Through the lens of predictive medicine, MEDICREA® leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room. Operating in a $10 billion marketplace, MEDICREA® is a Small and Medium sized Enterprise (SME) with 210 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient-specific implants. For further information, please visit: medicrea.com

NATEO HEALTHCARE is a dynamic start-up, co-founded by obstetrician-gynaecologists, medical technology specialists and business development and management seasoned experts. Based in Toulouse (France), we design and market connected medical devices and innovative software in the field of obstetrics. We are currently developing a new generation of mobile and connected CTG monitor for maternity hospitals and home fœtal telemonitoring.

Ouihelp is a developer of an online residential assistance platform designed to help seniors in their regular activities at home.

Therapixel is a leading french software company specialized in artificial intelligence for medical imaging. Our aim is to develop a digital radiologist achieving the performance of best experts. Our AI is dedicated to breast cancer screening. That algorithm won the Digital Mammography DREAM Challenge, the largest Artificial Intelligence challenge ever organized. In its early years, Therapixel developed images visualization software for surgeons to make image access easier and faster from patient consultation to the operating room thanks to gesture control and intuitive user interfaces.

Allibert Medical, Corona Medical and Sotec Medical unite to form the HAcare group. By relying on the know-how of our brands, and the expertise of our teams, we can support you in the choice and installation of medical equipment (medical bed, ambulatory chair, stretcher, etc.), the management of the medication circuit (trolley, cupboard, etc.), home support and fitting out of common living areas (bedside table, dining table, bridge, etc.).

BioSerenity is an innovative company that develops connected medical solutions to help the diagnosis and the monitoring of patients with chronic diseases in cardiology, neurology, and sleep disorders. BioSerenity uses physiological sensors, an IoT platform, apps and A.I. to detect digital biomarkers. We work today with more than 200 hospitals in Europe and in the USA and help diagnose over a hundred thousand patients per year. Our headquarter is in Paris, France. The US main office is located in greater Boston area (Danvers) in Massachusetts.

Axorus develops neuroelectronic interfaces to increase healthspan (sensory, motor and cognitive).

3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription

For nearly 30 years, Asept InMed has been developing health solutions in an innovative, responsible and sustainable spirit in the fields of gastroenterology, pulmonology, urology and infusion solutions. A key professional in the world of health thanks to its expertise in the distribution of single-use medical devices, our main mission is to support health establishments and providers. A subsidiary of the Medi-Globe Group, our company is united alongside innovative partners around different medical specialties.

Spring Thread®, c’est le traitement esthétique par fils tenseurs efficace pour un ovale du visage retrouvé : Lifting vertical, résultats immédiats, amélioration dans le temps et effet longue durée. Cette innovation esthétique française brevetée repositionne les tissus tout en maintenant les expressions naturelles du visage. Aboutissement de longues années de recherche, le fil esthétique permanent Spring Thread® apporte depuis 2007 une réponse efficace pour atténuer durablement l’affaissement de votre visage (appelée ptose) et de certaines parties du corps.

Le groupe GN est un leader mondial en solutions audio intelligentes [avec pour vocation de vous permettre de mieux entendre, de mieux faire et de mieux vivre et ce, au-delà de toutes vos attentes]. Notre ambitieux voyage de 150 ans nous a menés des câbles télégraphiques aux ondes radio puis à l’ingénierie de solutions audio intelligentes. Pour célébrer notre anniversaire, nous nous appuyons sur nos compétences uniques en matière de solutions audio médicales, professionnelles et grand public pour nous aider à continuer à transformer des vies grâce au pouvoir du son. GN a été fondé dans un esprit véritablement novateur et international. Aujourd’hui, nous honorons cet héritage avec une expertise de pointe mondiale en matière d’audition, de son, de technologie sans fil, de miniaturisation et de collaborations avec des partenaires technologiques de premier plan. Les solutions GN sont commercialisées sous les marques ReSound, Beltone, Interton, Jabra et BlueParrott dans 100 pays. Fondé en 1869, le groupe GN emploie plus de 6 000 personnes et est coté au Nasdaq de Copenhague (GN.CO).

BIOSENCY is a medical device company focused on developing smart healthcare solutions. Our first product, a connected PPG sensor system using smart data is a monitoring and prevention solution dedicated to respiratory insufficiency. Our company is based in Rennes, France. We work closely with doctors and researchers to bring to the medical community the best possible tools to help patients.

Fournisseur de matériel médical et chirurgical pour les professionnels de santé, Équipementier médica destiné aux pros de santé, toutes spécialités confondues, mairies, institutions, collectivités, cabinets privés, cliniques, petites et moyennes entreprises, matériel consommable et mobilier médical, couverture nationale, spécialisée Paris et IDF, Made in France, la majorité de nos produits sont certifiés Eco-label, Ecocert et répondent aux normes d'acheminement respectueuses de l'environnement

Besoin de visibilité pour votre activité ? Bew web Agency est votre partenaire qualité web ! Notre agence de création de site basée dans le 20e arrondissement de Paris vous propose à travers son savoir-faire des services dédiés à votre e-business naissant et/ou en quête d’expansion. Nos experts SEO, webmasters et développeurs s’adaptent aux demandes pour proposer des services sur mesure afin que le site internet réponde en tout point à l’image que renvoie l’entreprise. Engagé dans votre réussite, Bew Web vous accompagne afin d’améliorer la visibilité sur les moteurs de recherche grâce à son expertise référencement.